All Brands Owned by Eli Lilly and Company
Eli Lilly and Company owns 2 brands in our database. Browse the complete portfolio of Eli Lilly and Company subsidiaries and brands across various industries.
Company Type
public
Headquarters
Indianapolis, Indiana, USA
Brand Portfolio
2 brands
Stock
NYSE: LLY
Filter by Category
Showing pharmaceuticals-healthcare brands
2 of 2 total brands
pharmaceuticals-healthcare Brands
Mounjaro
Owned by Eli Lilly and Company
Pharmaceutical brand of tirzepatide injection for type 2 diabetes treatment, owned by Eli Lilly and Company.
Zepbound
Owned by Eli Lilly and Company
Prescription weight loss medication brand owned by Eli Lilly, containing tirzepatide as the active ingredient.
About Eli Lilly and Company
What does Eli Lilly make?
Eli Lilly makes prescription pharmaceuticals across several therapeutic areas. Its most important products are Mounjaro (tirzepatide for type 2 diabetes) and Zepbound (tirzepatide for obesity), which are dual GIP/GLP-1 receptor agonists. The company also makes Verzenio (breast cancer), Trulicity (diabetes), Taltz (psoriasis), Humalog (insulin), and Emgality (migraine).
Is Eli Lilly publicly traded?
Yes, Eli Lilly and Company is listed on NYSE under ticker LLY. Major institutional shareholders include Vanguard Group, BlackRock, and State Street.
Who founded Eli Lilly?
Eli Lilly was founded in 1876 in Indianapolis, Indiana by Colonel Eli Lilly, a Civil War veteran and pharmacist. The company made its first major breakthrough in 1923 when it produced commercial quantities of insulin.
Where is Eli Lilly headquartered?
Eli Lilly is headquartered in Indianapolis, Indiana, USA, where the company was founded in 1876. The company operates research and development centers, manufacturing facilities, and commercial operations in more than 120 countries.
What is Mounjaro and Zepbound?
Mounjaro and Zepbound both contain tirzepatide, a dual GIP/GLP-1 receptor agonist developed by Eli Lilly. Mounjaro is approved for type 2 diabetes, while Zepbound is approved for obesity. Tirzepatide has demonstrated superior efficacy to existing GLP-1 drugs in clinical trials, with patients losing an average of approximately 20% of their body weight in obesity trials.
Who owns Eli Lilly?
Eli Lilly and Company is publicly traded on NYSE with a broad institutional and retail shareholder base. No single shareholder holds a controlling stake. David Ricks serves as Chairman and CEO.
Stock Information
Competitors to Eli Lilly and Company
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Novo Nordisk | Denmark | 2017 | Mass Market | Global | All Genders | |
| Novo Nordisk | Denmark | 2021 | Mass Market | Global | All Genders |
Learn More About Competitors
Ozempic
Owned by Novo Nordisk
Prescription diabetes medication brand owned by Novo Nordisk, containing semaglutide as the active ingredient.
Wegovy
Owned by Novo Nordisk
Prescription weight loss medication brand owned by Novo Nordisk, containing semaglutide as the active ingredient.
Competitive Analysis
Market Positioning: Eli Lilly and Company competes with 2 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Eli Lilly and Company Brand Portfolio Overview
Eli Lilly and Company maintains a diverse portfolio of 2 brands across multiple industries. This comprehensive brand portfolio demonstrates the company's market presence and strategic business units.
Brand Portfolio by Industry:
- pharmaceuticals healthcare: 2 brands
For consumers and researchers interested in corporate ownership structures, understanding which brands are owned by Eli Lilly and Companyprovides valuable insights into market dynamics, product relationships, and corporate strategy.
Explore More
Jobs at Eli Lilly and Company
Latest News About Eli Lilly and Company
Articles About Eli Lilly and Company
View more articles
Pharmaceutical Brand Ownership: A Complete Guide
Who makes your medications? Discover which corporations own the biggest pharmaceutical brands, from Ozempic to Tylenol, and how pharma M&A affects you.
Monthly M&A Roundup: February 2026 Brand Ownership Changes
From Keurig Dr Pepper's planned split to the Netflix-WBD saga, here is every major brand ownership change and deal in February 2026.
The Most Acquired Categories: Tech vs CPG vs Pharma
Which industries see the most brand acquisitions? We compared technology, consumer goods, and pharmaceuticals to find out where the most M&A activity happens and why.